Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Published:2010-11-28 Issue:1 Volume:13 Page:65-74
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Taskinen M.-R.,Rosenstock J.,Tamminen I.,Kubiak R.,Patel S.,Dugi K. A.,Woerle H.-J.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2010.01326.x/fullpdf

Reference41 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030.;Shaw;Diabetes Res Clin Pract,2010

2. Mortality attributable to diabetes: estimates for the year 2010.;Roglic;Diabetes Res Clin Pract,2010

3. Standards of medical care in diabetes-2009.;American Diabetes Association.;Diabetes Care,2009

4. Timely addition of insulin to oral therapy for type 2 diabetes.;Riddle;Diabetes Care,2002

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models;JAMA Network Open;2024-05-22

2. Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials;Therapeutic Innovation & Regulatory Science;2024-04-18

3. Factors Correlated to the Renoprotective Effect of Sitagliptin in Patients with Type 2 Diabetes Mellitus: Retrospective Observational Study;Advances in Pharmacological and Pharmaceutical Sciences;2024-01

4. Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study;Hormone Molecular Biology and Clinical Investigation;2023-12-01

5. Budget impact of introducing oral semaglutide to the public healthcare benefit package in Saudi Arabia;Journal of Medical Economics;2023-11-08